Biomedical Engineering Reference
In-Depth Information
Hare J, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled,
dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after
acute myocardial infarction. J Am Coll Cardiol 2009;54:2277-86.
Harel-Adar T, Mordechai TB, Amsalem Y, et al. Modulation of cardiac macrophages by
phosphatidylserine-presenting liposomes improves infarct repair. Proc Natl Acad Sci USA
2011;108:1827-32.
Hata H, Matsumiya G, Miyagawa S, et al. Grafted skeletal myoblast sheets attenuate myocardial
remodeling in pacing-induced canine heart failure model. J Thorac Cardiovasc Surg 2006;
132:918-24.
Huang YC, Khait L, Birla RK. Contractile three-dimensional bioengineered heart muscle for
myocardial regeneration. J Biomed Mat Res Part A 2007;80:719-31.
Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional car-
diomyocytes by defined factors. Cell 2010;142:375-86.
Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular
endothelium by adult stem cells. J Clin Invest 2001;107:1395-402.
Jain KK. Cell Therapy: technologies, markets & companies. 2011, Jain PharmaBiotech
Publications, Basel, 2011.
Jo J, Nagaya N, Miyahara Y, et al. Transplantation of Genetically Engineered Mesenchymal Stem
Cells Improves Cardiac Function in Rats with Myocardial Infarction: Benefit of a Novel
Nonviral Vector, Cationized Dextran. Tissue Engineering 2007;13:313-322.
Kang H, Kim H, Zhang S, et al. Effects of intracoronary infusion of peripheral blood stem-cells
mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and
restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clini-
cal trial. Lancet 2004;363:751-56.
Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell
2009;4:206-16.
Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived
from human embryonic stem cells. Nat Biotech 2004;22:1282-9.
Kellar RS, Shepherd BR, Larson DF, et al. Cardiac patch constructed from human fibroblasts
attenuates reduction in cardiac function after acute infarct. Tissue Eng 2005;11:1678-87.
Kolossov E, Bostani T, Roell W, et al. Engraftment of engineered ES cell-derived cardiomyocytes
but not BM cells restores contractile function to the infarcted myocardium. J Exp Med
2006;203:2315-27.
Kraitchman DL, Tatsumi M, Gilson WD, et al. Dynamic imaging of allogeneic mesenchymal stem
cells trafficking to myocardial infarction. Circulation 2005;112:1451-61.
Kühn B, del Monte F, Hajjar RJ, et al. Periostin induces proliferation of differentiated cardiomyo-
cytes and promotes cardiac repair. Nat Med 2007;13:962-9.
Kusuyama T, Omura T, Nishiya D, et al. The effects of HMG-CoA reductase inhibitor on vascular
progenitor cells. J Pharmacol Sci 2006;101:344-9.
Kyrtatos PG, Lehtolainen P, Junemann-Ramirez M, et al. Magnetic Tagging Increases Delivery of
Circulating Progenitors in Vascular Injury. J Am Coll Cardiol Intv 2009;2:794-802.
Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic
stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotech
2007;25:1015-24.
Laflamme MA, Gold J, Xu C, Hassanipour M, et al. Formation of human myocardium in the rat
heart from human embryonic stem cells. Am J Pathol 2005;167:663-71.
Laugwitz KL, Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardio-
myocyte lineages. Nature 2005;433:647-653.
Lepilina A, Coon AN, Kikuchi K, et al. A Dynamic Epicardial Injury Response Supports
Progenitor Cell Activity during Zebrafish Heart Regeneration. Cell 2006;127:607-19.
Li TS, Takahashi M, Suzuki R, et al. Pravastatin improves remodeling and cardiac function after
myocardial infarction by an antiinflammatory mechanism rather than by the induction of
angiogenesis. Ann Thorac Surg 2006;81:2217-25.
Search WWH ::
Custom Search